|
Volumn 94, Issue 2, 2004, Pages 383-386
|
High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer
|
Author keywords
Clear cell endometrial cancer; High dose rate brachytherapy; Papillary serous
|
Indexed keywords
AGED;
ARTICLE;
CANCER CONTROL;
CANCER GRADING;
CANCER INVASION;
CANCER LOCALIZATION;
CANCER MORTALITY;
CANCER PATIENT;
CANCER RECURRENCE;
CANCER RISK;
CLEAR CELL CARCINOMA;
CLINICAL ARTICLE;
CONTROLLED STUDY;
ENDOMETRIUM CARCINOMA;
FEMALE;
FOLLOW UP;
HUMAN;
HYSTERECTOMY;
PAPILLARY CARCINOMA;
PARAAORTIC LYMPH NODE;
PELVIS LYMPHADENECTOMY;
PRIORITY JOURNAL;
RADIATION DOSE FRACTIONATION;
RADIOISOTOPE THERAPY;
RISK ASSESSMENT;
ADENOCARCINOMA, CLEAR CELL;
AGED;
BRACHYTHERAPY;
CYSTADENOCARCINOMA, PAPILLARY;
CYSTADENOCARCINOMA, SEROUS;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMANS;
IRIDIUM RADIOISOTOPES;
MIDDLE AGED;
NEOPLASM STAGING;
RADIOPHARMACEUTICALS;
RETROSPECTIVE STUDIES;
|
EID: 3543078092
PISSN: 00908258
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ygyno.2004.05.009 Document Type: Article |
Times cited : (29)
|
References (7)
|